Cubist Systematic Strategies, LLC Pliant Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$18.12 - $30.56 $3.27 Million - $5.51 Million	-180,455 Reduced 74.77%	60,883 $1.1 Million
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $3.35 Million - $6.48 Million	178,608 Added 284.73%	241,338 $6.42 Million
Q4 2022 Feb 14, 2023	SELL	$17.0 - $25.43 $678,385 - $1.01 Million	-39,905 Reduced 38.88%	62,730 $1.21 Million
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $393,586 - $1.24 Million	51,315 Added 99.99%	102,635 $2.14 Million
Q2 2022 Aug 15, 2022	BUY	$4.11 - $8.75 $135,243 - $287,927	32,906 Added 178.7%	51,320 $411,000
Q1 2022 May 16, 2022	BUY	$7.01 - $14.1 $52,848 - $106,299	7,539 Added 69.32%	18,414 $129,000
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.26 $133,436 - $198,577	10,875 New	10,875 $147,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.